We are live on ! Find out more
LABS

Direxion Daily S&P Biotech Bear 1X Shares
LABS

Delisted

LABS was delisted on the 25th of September, 2017.

Back to rankings

2 hedge funds and large institutions have $1.13M invested in Direxion Daily S&P Biotech Bear 1X Shares in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

41% less capital invested

Capital invested by funds: $1.9M → $1.13M (-$773K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$809K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$2.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$797K +$809K +15,083 New
VF
2
Virtu Financial
New York
$330K -$2.19M -40,838 -86%

LABS Hedge Fund Activity: Q1 2016 in Review

2 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 1X Shares (LABS) for Q1 2016, worth a combined $1.13M — down 41% from $1.9M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new LABS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $809K. The largest seller was Virtu Financial, cutting an estimated $2.19M.

  • 2 institutional investors held Direxion Daily S&P Biotech Bear 1X Shares (LABS) as of Q1 2016, up from 1 in Q4 2015.
  • Funds reported $1.13M of Direxion Daily S&P Biotech Bear 1X Shares stock for Q1 2016, down 41% quarter-over-quarter.
  • 1 fund opened new Direxion Daily S&P Biotech Bear 1X Shares positions in Q1 2016 and 0 closed out, a net change of +1 holder.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares buyer in Q1 2016 was Jane Street, an estimated $809K added.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares seller in Q1 2016 was Virtu Financial, an estimated $2.19M sold.

Based on aggregated 13F filings for Q1 2016.